Editorial: Adaptive immune resistance in cancer therapy
Aimin Jiang,
Ouyang Chen,
Zhigang Liu,
Hongzhou Cai,
Linhui Wang,
Lin Qi,
Lin Qi
Affiliations
Aimin Jiang
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
Ouyang Chen
Department of Cell Biology, Duke University Medical Center, Durham, NC, United States
Zhigang Liu
Dongguan Key Laboratory of Precision Diagnosis and Treatment for Tumors, Dongguan, Guangdong, China
Hongzhou Cai
Department of Urology, Jiangsu Cancer Hospital and The Affiliated Cancer Hospital of Nanjing Medical University and Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, China
Linhui Wang
Department of Urology, Changhai Hospital, Naval Medical University, Shanghai, China
Lin Qi
Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China
Lin Qi
Hunan Key Laboratory of Tumor Models and Individualized Medicine, The Second Xiangya Hospital, Changsha, Hunan, China